Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram vs Risperidone for BPSD in Alzheimer's Disease
NCT01119638Phase 4Completed
- Sponsor
- Abarbanel Mental Health Center
- Start
- Apr 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of escitalopram in Alzheimer's disease (AD) (2 arms), sponsored by Abarbanel Mental Health Center. Primary endpoint: Neuropsychiatric Inventory at 6 weeks. Started Apr 2008; status: completed.
02
Drugs
escitalopram
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01119638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01119638.